Assessment of the psychological effects of genetic screening for hereditary hemochromatosis

被引:5
作者
Elsass, Peter [1 ,2 ]
Pedersen, Palle
Husum, Kristian [2 ]
Milman, Nils [3 ]
机构
[1] Hosp Naestved, Dept Clin Biochem, DK-4700 Naestved, Denmark
[2] Univ Copenhagen, Inst Psychol, Copenhagen, Denmark
[3] Univ Copenhagen Hosp, Rigshosp, Ctr Heart, Dept Med B, DK-2100 Copenhagen, Denmark
关键词
hemochromatosis; genetic screening; personal genetic information; prospective study; psychological factors;
D O I
10.1007/s00277-007-0415-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Discovery of genetic variants of the HFE gene has made it possible to screen for hereditary hemochromatosis. However, genetic screening raises ethical, legal, social, and psychological questions, which need to be addressed. To assess the psychological impact on individuals undergoing genetic screening for hereditary hemochromatosis and to determine the effects of providing different levels of information to the participants. Male residents, aged 30-50 years (n=10,993) were invited to a genetic screening for hereditary hemochromatosis. Carriers of the gene variants H63D, S65C, and C282Y were offered additional biochemical screening using serum ferritin and transferrin saturation. Psychological factors were evaluated through questionnaires before and after genetic and biochemical screening. According to genotype, participants were divided into three groups with different risks profiles for having/developing clinical hemochromatosis (at-risk, uncertain risk, no risk). Before completion of the questionnaires, 929 participants received only genetic information and 366 received both genetic and biochemical information. At-risk participants receiving only genetic information generally displayed negative reactions to the test result, whereas participants receiving both genetic and biochemical information were more satisfied and had fewer negative psychological reactions to the test result. Genetic screening is more readily accepted by subjects when genetic information is supported by biochemical measurements, especially in participants with a risk of clinical disease.
引用
收藏
页码:397 / 404
页数:8
相关论文
共 50 条
  • [21] Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis
    Chandrasekharan, Subhashini
    Pitlick, Emily
    Heaney, Christopher
    Cook-Deegan, Robert
    GENETICS IN MEDICINE, 2010, 12 (04) : S155 - S170
  • [22] Recent advances in hereditary hemochromatosis
    Massimo Franchini
    Dino Veneri
    Annals of Hematology, 2005, 84 : 347 - 352
  • [23] Liver transplantation for hereditary hemochromatosis
    Poulos, JE
    Bacon, BR
    DIGESTIVE DISEASES, 1996, 14 (05) : 316 - 322
  • [24] The Molecular Pathogenesis of Hereditary Hemochromatosis
    Babitt, Jodie L.
    Lin, Herbert Y.
    SEMINARS IN LIVER DISEASE, 2011, 31 (03) : 280 - 292
  • [25] Clinical perspectives on hereditary hemochromatosis
    Ayonrinde, Oyekoya T.
    Milward, Elizabeth A.
    Chua, Anita C. G.
    Trinder, Debbie
    Olynyk, John K.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2008, 45 (05) : 451 - 484
  • [26] Diagnosis and treatment in hereditary hemochromatosis
    von Figura, G.
    Kulaksiz, H.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (50) : 2565 - 2572
  • [27] Recent advances in hereditary hemochromatosis
    Franchini, M
    Veneri, D
    ANNALS OF HEMATOLOGY, 2005, 84 (06) : 347 - 352
  • [28] New developments in hereditary hemochromatosis
    Felitti, VJ
    Beutler, E
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1999, 318 (04) : 257 - 268
  • [29] Hereditary hemochromatosis -: Update 2000
    Erhardt, A
    Niederau, C
    Häussinger, D
    MEDIZINISCHE WELT, 2000, 51 (06): : 179 - 185
  • [30] Educational outcomes of a workplace screening program for genetic susceptibility to hemochromatosis
    Nisselle, AE
    Collins, VR
    Gason, AA
    Flouris, A
    Delatycki, MB
    Allen, KJ
    Aitken, MA
    Metcalfe, SA
    CLINICAL GENETICS, 2006, 69 (02) : 163 - 170